The Cambridge-1 supercomputer, the most powerful supercomputer in the United Kingdom, was inaugurated this Wednesday, July 7 in Harlow, England. This artificial health intelligence, powered by fully renewable energies, will be essentially dedicated to researching new drugs, to treatments and syntheses of medical imaging, and to genomic analyzes.
Nvidia today presented its first Cambridge-1 supercomputer, an artificial intelligence dedicated to health. Classified at 42e rank of the most powerful supercomputers in the world (Top 500), thirdEuropean machine, the machine will offer a computing capacity of 400 petaflops of artificial intelligence performance, and eight Linpack performance petaflops (system resolution of linear). Powered by fully renewable, it is one of the five most energy efficient supercomputers.
Supercomputing to the rescue of vaccines?
« Cambridge-1’s impact will be global, fostering ground-breaking research from which millions of people can benefit », Said Jensen Huang, CEO of Nvidia. Booming in the UK, healthcare AI could be of great help to patients, especially through the combination of big data and IT. If the traditional development ofis long, expensive, and very uncertain, the Cambridge-1 will facilitate research. Likewise, in the field of immuno-oncology, the machine could play a key role in determining the best treatment for the patient.
The crisis ofhad put in the interest of associating high performance computing with . « Faced with the arrival of variants, supercomputing could allow vaccines to be quickly adapted “Said Craig Rhodes, head of artificial intelligence for health and biology at Nvidia in industry in Europe, the Middle East and Africa.